Register      Login

VOLUME 1 , ISSUE 1 ( January-March, 2022 ) > List of Articles

Article Commentary

Rethinking the Paradigm: The Evolving Care of Children with Trisomy 13 and 18

Kimberly L Spence, Erica K Salter

Keywords : Ethics, Trisomy 13, Trisomy 18

Citation Information : Spence KL, Salter EK. Rethinking the Paradigm: The Evolving Care of Children with Trisomy 13 and 18. 2022; 1 (1):197-200.

DOI: 10.5005/jp-journals-11002-0007

License: CC BY-NC 4.0

Published Online: 31-03-2022

Copyright Statement:  Copyright © 2022; The Author(s).


A chromosomal evaluation should be used to provide better care for a child and their family, not limit it. However, in many pediatric institutions, the diagnosis of a chromosomal abnormality automatically circumscribes the medical and surgical options made available to the family. For example, alongside many other comorbidities (including severe cognitive impairment), infants diagnosed with trisomy 13 or 18 (T13/18) often have cognitive heart defects (e.g., atrial or ventricular septal defects, patent ductus arteriosus, atrioventricular septal defects) that can be successfully repaired or palliated in the general population. However, because T13/18 have historically been considered “lethal” diagnoses or “incompatible with life”, surgical correction of these defects is not frequently offered, and instead infants with these diagnoses are managed with a noninterventionist, “comfort care” approach in which the infant is simply allowed to expire after birth. In recent years, however, more data have emerged from centers that regularly pursue medical and surgical interventions in this population, demonstrating improved outcomes in both quality and quantity of life. Simultaneously, the pediatric ethics literature has argued that treatment decisions for infants with T13/18 are frequently informed by unfounded biases concerning disability and quality of life. Now that neonatology is equipped with improved medical and ethical evidence, the practice of categorically excluding infants with a T13/18 diagnosis from life-saving interventions should be challenged, and instead, parents of these infants should be offered targeted interventions, including corrective and palliative procedures, and included in the process of shared decision-making about which interventions best meet the family's goals of care.

  1. Wilkinson D, deCrespigny L, Xafis V. Ethical Language and Decision-making for Prenatally Diagnosed Lethal Malformation. Semin Fetal Neonatal Med 2014;19(5):306–311. DOI: 10.1016/j.siny.2014.08.007.
  2. Nelson KE, Rosella LC, Mahant S, et al. Survival and Surgical Interventions for Children with Trisomy 13 and 18. Journal of the American Medical Association 2016;316(4):420–428. DOI: 10.1001/jama.2016.9819.
  3. Peterson R, Calamur N, Fiore A, et al. Factors Influencing Outcomes After Cardiac Intervention in Infants with Trisomy 13 and 18. Pediatr Cardiol 2018; 39(1):140–147. DOI: 10.1007/s00246-017-1738-y.
  4. Weaver M, Anderson V, Beck J, et al. Interdisciplinary Care of Children with Trisomy 13 and 18. Am J Med Genet 2021;185A: 966–977. DOI: 10.1002/ajmg.a.62051.
  5. US Congress Public Law 98-457, “Child Abuse Amendments of 1984”.
  6. Yang Q, Rasmussen SA, Friedman JM. Mortality associated with Down's syndrome in the USA from 1983 to 1997: A Population-based Study. Lancet 2002;23;359(9311):1019–1025. DOI: 10.1016/s0140-6736(02)08092-3.
  7. Leonard S, Bower C, Petterson B, et al. Survival of Infants Born with Down's Syndrome: 1980-96. Paediatr Perinat Epidemiol 2000;14(2):163–1671. DOI: 10.1046/j.1365-3016.2000.00252.x.
  8. Bull C, Rigby ML, Shinebourne EA. Should Management of Complete Atrioventricular Canal Defect be Influenced by Coexistent Down Syndrome? Lancet 1985;18;1(8438):1147–1149. DOI: 10.1016/s0140-6736(85)92444-4.
  9. Rasmussen SA, Wong LY, Yang Q, et al. Population-based Analyses of Mortality in Trisomy 13 and Trisomy 18. Pediatrics 2003; 111(4 Pt 1): 777–784. DOI: 10.1542/peds.111.4.777.
  10. Pallotto I, Lantos J. Treatment Decisions for Babies with Trisomy 13 and 18. HEC Forum 2017;29(3):213–222. DOI:10.1007/s10730-017-9319-2.
  11. Janvier A, Farlow B, Wilfond B. The Experience of Families with Children with Trisomy 13 and Trisomy 18 in Social Networks. Pediatrics 2012;130(2): 293–298. DOI: 10.1542/peds.2012-0151.
  12. Graham EM, Bradley SM, Shirali GS, et al. Pediatric Cardiac Care Consortium. Effectiveness of Cardiac Surgery in Trisomies 13 and 18 (from the Pediatric Cardiac Care Consortium). Am J Cardiol 2004;15;93(6):801–803. DOI: 10.1016/j.amjcard.2003.12.012.
  13. Kaneko Y, Kobayashi J, Achiwa I, et al. Cardiac surgery in patients with trisomy 18. Pediatr Cardiol 2009;30(6):729–734. DOI: 10.1007/s00246-009-9427-0
  14. Maeda J, Yamagishi H, Furutani Y, et al. The impact of cardiac surgery in patients with trisomy 18 and trisomy 13 in Japan. Am J Med Genet Part A 2011;155: 2641–2646. DOI: 10.1002/ajmg.a.34285.
  15. Costello JP, Weiderhold A, Louis C, et al. A Contemporary, Single-Institutional Experience of Surgical Versus Expectant Management of Congenital Heart Disease in Trisomy 13 and 18 Patients. Pediatr Cardiol 2015;36:987–992. DOI: 10.1007/s00246-015-1109-5.
  16. Nishi E, Takamizawa S, Iio K, Yamada Y, et al. Surgical intervention for esophageal atresia in patients with trisomy 18. Am J Med Genet A 2014;164A(2):324–330. DOI: 10.1002/ajmg.a.36294.
  17. Carvajal HG, Callahan CP, Miller JR, et al. Cardiac Surgery in Trisomy 13 and 18: A Guide to Clinical Decision-Making. Pediatr Cardiol 2020; 41:1319–1333. DOI: 10.1007/s00246-020-02444-6.
  18. Meyer RE, Liu G, Gilboa SM, et al. National Birth Defects Prevention Network. Survival of Children with Trisomy 13 and Trisomy 18: A Multi-state Population-based Study. Am J Med Genet A 2016;170A(4): 825–837. DOI: 10.1002/ajmg.a.37495.
  19. Gary L Albrecht, Patrick J Devlieger. The Disability Paradox: High Quality of Life Against all Odds. Soc Sci Med 1999;48(8):977–988. DOI: 10.1016/s0277-9536(98)00411-0.
  20. Ubel PA, Loewenstein G, Schwarz N, et al. Misimagining the Unimaginable: The Disability Paradox and Health Care Decision Making. Health Psychol 2005;24(Suppl 4):S57–S62. DOI: 10.1037/0278-6133.24.4.S57.
  21. Shelly A, Davis E, Waters E, et al. The Relationship between Quality of Life and Functioning for Children with Cerebral Palsy. Dev Med Child Neurol 2008;50(3);199–203. DOI: 10.1111/j.1469-8749.2008.02031.x.
  22. Carey JC. Perspectives on the Care and Management of Infants with Trisomy 18 and Trisomy 13: Striving for Balance. Curr Opin Pediatr 2012;24(6):672–678. DOI: 10.1097/MOP.0b013e3283595031.
  23. Liang CA, Braddock BA, Heithaus JL, et al. Reported Communication Ability of Persons with Trisomy 18 and Trisomy 13. Dev Neurorehabil 2015;18(5):322–329. DOI: 10.3109/17518423.2013.847980.
  24. Braddock B, McDaniel J, et al. Communication Ability in Persons with Trisomy 18 and Trisomy 13. Augment Altern Commun 2012;28(4): 266–277. DOI: 10.3109/07434618.2012.706637.
  25. Bruns J. Erring on the Side of Life: Children with Rarer Trisomy Conditions, Medical Interventions and Quality of Life. Genet Disor Genet Rep 2013;2:1. DOI: 10.4172/2324-9331.1000103.
  26. Arthur J, Gupta D. You Can Carry the Torch Now: A Qualitative Analysis of Parents’ Experiences Caring for a Child with Trisomy 13 or 18. HEC Forum 2017;29(3):223–240. DOI: 10.1007/s10730-017-9324-5.
  27. Janvier A, Watkins A. Medical Interventions for Children with Trisomy 13 and Trisomy 18: What is the Value of a Short Disabled Life? Acta Paediatr 2013;102(12):1112–1117. DOI: 10.1111/apa.12424.
  28. Weaver M, Birge N, Hsu H, et al. Mixed Method Study of Quality of Life for Children with Trisomy 18 and 13 after Cardiac Surgery. Cardiol Young 2020;30(2):231–237. DOI: 10.1017/S104795112 0000013.
  29. Kett J. Who is the Next Baby Doe? From Trisomy 21 to Trisomy 13 and 18 and Beyond. Pediatrics 2020;146(Suppl 1):S9–S12. DOI: 10.1542/peds.2020-0818D.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.